This HTML5 document contains 119 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
n12	http://dx.doi.org/10.1016/
schema	http://schema.org/
rdfs	http://www.w3.org/2000/01/rdf-schema#
skos	http://www.w3.org/2004/02/skos/core#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n10	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q53128299

rdf:type

wikibase:Item

schema:description

scienca artikolo tieteellinen artikkeli 2012 nî lūn-bûn vitenskapelig artikkel научная статья scientific article published in June 2012 2012年学术文章 2012年學術文章 2012年学术文章 מאמר מדעי artigo científico мақолаи илмӣ vědecký článek 2012年学术文章 articol științific article scientific bài báo khoa học научни чланак наукова стаття, опублікована в червні 2012 vitskapeleg artikkel article científic 2012年學術文章 2012年学术文章 artigo científico научни чланак wissenschaftlicher Artikel scientific article published in June 2012 জুন ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artículo científico publicado en 2012 teaduslik artikkel مقالة علمية نشرت في يونيو 2012 2012년 논문 artykuł naukowy tudományos cikk artikull shkencor 2012年学术文章 บทความทางวิทยาศาสตร์ artigo científico vetenskaplig artikel articolo scientifico article scientifique научна статия 2012年學術文章 artikel ilmiah 2012年學術文章 artikulong pang-agham artículu científicu სამეცნიერო სტატია vedecký článok scientific article published in June 2012 2012年學術文章 επιστημονικό άρθρο videnskabelig artikel 2012年学术文章 bilimsel makale 2012年の論文 wetenschappelijk artikel naučni članak

p:P577

wds:Q53128299-824A94DE-3F47-45FF-8A2D-D79EE2602310

wdt:P577

2012-06-01T00:00:00Z

p:P407

wds:Q53128299-7BBBFBBA-9F82-4907-AE73-43E952B74FE2

wdt:P407

wd:Q1860

p:P2093

wds:Q53128299-EFE60CA9-66F8-488F-9BD8-86C9AFC709BD wds:Q53128299-D98F1E39-5E8B-41A7-A146-60D17B35F71A wds:Q53128299-7BFA903B-12BE-403F-9881-9D2726D1C025 wds:Q53128299-2DD359F6-5C41-4412-8F1C-B8703D4DB17C

wdt:P2093

Ruth Harper Sebastian Härtter Martina Brueckmann Stuart J Connolly

rdfs:label

A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN) A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN)

skos:prefLabel

A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN) A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN)

schema:name

A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN) A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN)

p:P50

wds:Q53128299-F35E602F-F36D-4A84-B4DF-36227457625A wds:Q53128299-D170024D-FDF3-481D-AC05-84FE65DF391A wds:Q53128299-3504CC6D-3025-4606-94CF-590C641C9275 wds:Q53128299-B039F9AD-0CD4-4B80-877A-3C67B0962534 wds:Q53128299-83697FC8-4F90-45B3-97B4-3C1CD3E3D43F wds:Q53128299-890524C2-AA39-4DF8-AE1D-C463857A08CE wds:Q53128299-24D7B222-0941-48A3-970C-B348EF773DB4 wds:Q53128299-2E4473EC-E3A6-4745-ACFE-9CBD7ED20341

wdt:P50

wd:Q112157941 wd:Q5492406 wd:Q44003025 wd:Q97653175 wd:Q62050240 wd:Q89534351 wd:Q42846212 wd:Q59689017

p:P1476

wds:Q53128299-AAE72F45-8757-47E2-8370-4F3ADF827DB5

wdt:P1476

A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN)

p:P304

wds:Q53128299-3D72D534-5F0D-4F88-BB3F-113900723069

wdt:P304

931-937.e1

p:P31

wds:Q53128299-362428C9-A16B-4D29-A998-70239505F63C

wdt:P31

wd:Q13442814

p:P921

wds:Q53128299-5478543A-9DA2-4E23-9E2D-A67AFC29D9EA wds:Q53128299-32C64A2B-AC4D-4CA6-BB45-5929E40981B3 wds:Q53128299-A15D75D9-F218-430B-92CE-50DDB9F1D150 wds:Q53128299-C0B5E798-3BCA-4D4A-B1FA-F9A5079A50D7

wdt:P921

wd:Q419345 wd:Q323936 wd:Q181600 wd:Q407431

p:P698

wds:Q53128299-BC464293-BC04-404E-B737-6C5316F1AEB0

wdtn:P698

n10:22709744

wdt:P698

22709744

p:P1433

wds:Q53128299-CC52CDAC-808B-4512-B9E6-DC0A93DAE405

wdt:P1433

wd:Q2227156

p:P433

wds:Q53128299-011104DF-A593-4E1B-B86A-ED368111554B

p:P478

wds:Q53128299-B633D451-0C5B-47BF-BB4C-88A79C46C208

wdt:P433

6

wdt:P478

163

p:P356

wds:Q53128299-37863E19-B70E-4C1C-AD85-D9BAAA9D59C2

wdtn:P356

n12:J.AHJ.2012.03.011

wdt:P356

10.1016/J.AHJ.2012.03.011